|
Volumn 60, Issue 9, 2007, Pages 1069-1070
|
Mucin 2 (MUC2) and mucin 5 (MUC5) expression is not associated with prognosis in patients with radically resected ampullary carcinoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GLYCOPROTEIN;
MONOCLONAL ANTIBODY;
MUCIN 2;
MUCIN 5;
STREPTAVIDIN;
UNCLASSIFIED DRUG;
ADULT;
AGED;
AMPULLARY CANCER;
ARTICLE;
CANCER SURVIVAL;
CLINICAL ARTICLE;
DEATH;
FEMALE;
FOLLOW UP;
HISTOLOGY;
HUMAN;
HUMAN TISSUE;
IMMUNOCOMPETENT CELL;
IMMUNOHISTOCHEMISTRY;
IMMUNOREACTIVITY;
INTESTINE CANCER;
KAPLAN MEIER METHOD;
LOG RANK TEST;
MALE;
MINIMAL RESIDUAL DISEASE;
OVERALL SURVIVAL;
PANCREATICODUODENECTOMY;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN EXPRESSION;
QUANTITATIVE ANALYSIS;
STATISTICAL SIGNIFICANCE;
SURVIVAL TIME;
TUMOR CELL;
TUMOR VOLUME;
TWO TAILED TEST;
UNIVARIATE ANALYSIS;
ADULT;
AGED;
AGED, 80 AND OVER;
AMPULLA OF VATER;
COMMON BILE DUCT NEOPLASMS;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MUCINS;
NEOPLASM PROTEINS;
PROGNOSIS;
SURVIVAL ANALYSIS;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 34548828532
PISSN: 00219746
EISSN: None
Source Type: Journal
DOI: 10.1136/jcp.2005.035832 Document Type: Article |
Times cited : (7)
|
References (9)
|